Skip to content

NETs Formation in Patients With Recurrent Pyogenic Infections (NETS)

The Ability of Neutrophils From Patients With Recurrent Infections to Produce Neutrophil Extracellular Traps (NET).

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01112592
Acronym
NETs
Enrollment
100
Registered
2010-04-28
Start date
2010-05-31
Completion date
2013-12-31
Last updated
2013-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pyogenic Infections

Keywords

NETs, Infections, Neutrophil function

Brief summary

We aim to study if pathological NETs formation could be the underlying pathology among patients with recurrent infections and a normal screening of the immune system.

Detailed description

Our laboratory at Meir Medical Center, Kfar Saba, is the country's main center for neutrophil function, and serves about 80% of Israel's population. Patients are referred subsequent to recurrent, persistent, or unusual infections and after completing preliminary screening of the immune system and ruling out a humoral, cellular or complement immune deficiency. Initial workup includes chemotaxis, superoxide production (SOP), and bactericidal activity (BA). Based on test findings, further evaluation for a qualitative phagocytic disorder is conducted. Overall, impairment of phagocytic activity is found in about 33% (impaired chemotaxis in 16%, SOP in 6%, and BA in 24%). In the other 67%, no impairment of the immune function is found that can explain their tendency for recurrent pyogenic infections. In 2004 a novel function of the neutrophil was identified: formation of neutrophil extracellular traps (NETs). Apparently, neutrophils are able to extrude part of their cellular contents in the form of DNA, histones and proteases, to form extra cellular NETS that trap and kill bacterial pathogens without the need for phagocytosis. We aim to study if pathological NETs formation could be the underlying pathology among these patients with recurrent infections and a normal screening of the immune system.

Interventions

None listed

Sponsors

Max Planck Institute for Infection Biology
CollaboratorOTHER
Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients with recurrent, persistent, or unusual infections * Referred for Neutrophil Functions

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Measure NET formation in patients with recurrent infectionsOne year

Countries

Israel

Contacts

Primary ContactRonit Gavrieli, MSc
ronitgav@clalit.org.il972-9-7472399

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026